Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction

Author： Schofer Joachim Bode Christoph Silber Sigmund

ISSN： 0340-9937

Source： Herz, Vol.29, Iss.2, 2004-03, pp. : 195-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

In-stent restenosis of drug-eluting stents

By Minha Sa’ar Pichard Augusto D Waksman Ron

Future Cardiology, Vol. 9, Iss. 5, 2013-09 ,pp. : 721-731

Future Medicine

Access to resources Recommend Favorite

Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation

By Park Hyo

The International Journal of Cardiovascular Imaging, Vol. 28, Iss. 8, 2012-12 ,pp. : 2125-2134

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Mechanisms of In-Stent Restenosis and Approach to Therapy with Eluting Stents

By Indolfi C. Mongiardo A. Curcio A. Torella D.

Trends in Cardiovascular Medicine, Vol. 13, Iss. 4, 2003-05 ,pp. : 142-148

Elsevier

Access to resources Recommend Favorite

Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction: Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombus-laden lesions

By Weber F. Schneider H. Schwarz C. Holzhausen C. Petzsch M. Nienaber C.

Zeitschrift für Kardiologie, Vol. 93, Iss. 12, 2004-12 ,pp. : 938-943

Springer Publishing Company

Access to resources Recommend Favorite

Stent Selection in Patients with Myocardial Infarction: Drug Eluting, Biodegradable Polymers or Bare Metal Stents?

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 105-120

Bentham Science Publishers

Access to resources Recommend Favorite